Saiyad Bastaminejad and Salar Bakhtiyari* Pages 385 - 391 ( 7 )
COVID-19 is an emerging disease that is a major threat to the global community. The main challenge in this disease is the lack of proper or proven medication. The drugs used to treat this disease are only for symptomatic treatment. Studies of other coronaviruses, such as SARS and MERS, suggest that quercetin has sufficient potential to treat COVID-19. Previous studies have shown that quercetin reduces the entry of the virus into the cell by blocking the ACE2 receptor, as well as reducing the level of interleukin-6 in SARS and MERS patients. Therefore, the aim of this review was to scrutinize the potential of quercetin as a drug in the treatment of COVID-19 from a molecular perspective.
Quercetin, therapeutic, COVID-19, ACE2, SARS, MERS.
Department of Molecular Medicine, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Department of Clinical Biochemistry, Faculty of Medicine, Ilam University of Medical Sciences, Ilam